KRAS and cancer: Along with affecting the KRAS-associated pathways, the possible effect of KRAS mutation on the gene expression of other signaling pathways such as those related to Rho-GTPase cycle, TOR signaling, TGF-beta regulation of extracellular matrix, proteoglycans in cancer, and pathways in the cancer is one of the important results of this study.